Tumor-infiltrating, interleukin-33-producing effector-memory CD8+T cells in resected hepatocellular carcinoma prolong patient survival

Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer

(2015) Tiago Baptista et al.   Oncotarget

Correlations Between Serum IL33 and Tumor Development: a Meta-analysis

(2014) Xiang-Jun Chen et al.   Asian Pacific Journal of Cancer Prevention

Serum soluble ST2 is associated with ER-positive breast cancer

(2014) Da-peng Lu et al.   BMC CANCER

Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity

(2014) Daniel O. Villarreal et al.   CANCER RESEARCH

HMMR Maintains the Stemness and Tumorigenicity of Glioblastoma Stem-like Cells

(2014) J. Tilghman et al.   CANCER RESEARCH

Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis

(2014) L. Gopinathan et al.   CANCER RESEARCH

IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy

(2014) Corinne Cayrol et al.   CURRENT OPINION IN IMMUNOLOGY

Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers

(2014) Allison S. Cleary et al.   NATURE

The FEN1 E359K germline mutation disrupts the FEN1–WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers

(2014) L Chung et al.   ONCOGENE

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma

(2014) Dominik Bergis et al.   Translational Oncology

Invariant NKT cells

(2014) Hamid Bassiri et al.   OncoImmunology

Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle

(2013) Jacqueline M. Major et al.   ANNALS OF EPIDEMIOLOGY

Immunodominance and functional alterations of tumor-associated antigen-specific CD8+T-cell responses in hepatocellular carcinoma

(2013) Tobias Flecken et al.   HEPATOLOGY

Antitumor CD8+T cells in hepatocellular carcinoma: Present but exhausted

(2013) Ka-Kit Li et al.   HEPATOLOGY

Effector-like CD8+ T Cells in the Memory Population Mediate Potent Protective Immunity

(2013) Janelle A. Olson et al.   IMMUNITY

The Interleukin-1 Family: Back to the Future

(2013) Cecilia Garlanda et al.   IMMUNITY

Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells

(2013) Ivan P. Jovanovic et al.   INTERNATIONAL JOURNAL OF CANCER

Intrahepatic interleukin-17+T cells and FoxP3+regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma

(2013) Yong Huang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Inflammatory Cytokine-Mediated Evasion of Virus-Induced Tumors from NK Cell Control

(2013) R. Mishra et al.   JOURNAL OF IMMUNOLOGY

Detection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications

(2013) P Zhang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma

(2013) Su-Feng Chen et al.   JOURNAL OF PATHOLOGY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis

(2013) Fumihiko Uchida et al.   PLoS One

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization

(2013) Jian-Hong Zhong et al.   PLoS One

Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)

(2013) Rita Alaggio et al.   PLoS One

Neutralization of terminal differentiation in gliomagenesis

(2013) Jian Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FGF-2 Disrupts Mitotic Stability in Prostate Cancer through the Intracellular Trafficking Protein CEP57

(2012) R. Cuevas et al.   CANCER RESEARCH

Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors

(2012) S. van Duikeren et al.   JOURNAL OF IMMUNOLOGY

The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses

(2012) W. V. Bonilla et al.   SCIENCE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Molecular Basis of CRL4DDB2/CSA Ubiquitin Ligase Architecture, Targeting, and Activation

(2011) Eric S. Fischer et al.   CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Interleukin-33 prolongs allograft survival during chronic cardiac rejection

(2011) Stefan M. Brunner et al.   TRANSPLANT INTERNATIONAL

Immune Responses in Hepatocellular Carcinoma

(2010) Firouzeh Korangy et al.   DIGESTIVE DISEASES

Functional elucidation and methylation-mediated downregulation of ITGA5 gene in breast cancer cell line MDA-MB-468

(2010) Zhengyu Fang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

(2010) Daniel R. Neill et al.   NATURE

Immunotherapy of hepatocellular carcinoma

(2010) Firouzeh Korangy et al.   Expert Review of Gastroenterology & Hepatology

Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma

(2009) Kazumasa Hiroishi et al.   JOURNAL OF GASTROENTEROLOGY

Dok-4 Is a Novel Negative Regulator of T Cell Activation

(2009) A. Gerard et al.   JOURNAL OF IMMUNOLOGY

Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells

(2009) Kazuyo Moro et al.   NATURE

Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes

(2009) Andreas Lingel et al.   STRUCTURE